These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9102317)
1. [New antipsychotic agents: new paths of research on the notion of atypical agents]. Gosselin O; Di Scala G; Ribeyre JM; Kahn JP Encephale; 1996 Dec; 22 Spec No 6():3-6. PubMed ID: 9102317 [TBL] [Abstract][Full Text] [Related]
2. Novel pharmacological approaches to the treatment of schizophrenia. Fink-Jensen A Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983 [TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
7. [Atypical neuroleptics. Review of the available clinical data]. Verhoeven WM; Den Boer JA Encephale; 1990; 16(6):439-44. PubMed ID: 1983216 [TBL] [Abstract][Full Text] [Related]
8. [The chances of new atypical substances]. Falkai P; Vogeley K Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S32-7. PubMed ID: 10907611 [TBL] [Abstract][Full Text] [Related]
9. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality. Heresco-Levy U Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1113-23. PubMed ID: 14642971 [TBL] [Abstract][Full Text] [Related]
10. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia. Bishnoi M; Kumar A; Chopra K; Kulkarni SK Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557 [TBL] [Abstract][Full Text] [Related]
11. Atypical neuroleptics in the treatment of early onset schizophrenia. Masi G Panminerva Med; 1997 Sep; 39(3):215-21. PubMed ID: 9360425 [TBL] [Abstract][Full Text] [Related]
12. Serotonin receptors: their key role in drugs to treat schizophrenia. Meltzer HY; Li Z; Kaneda Y; Ichikawa J Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974 [TBL] [Abstract][Full Text] [Related]
13. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals]. Bret P; Bret MC; Queuille E Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacology of second-generation antipsychotics: a validity of the serotonin-dopamine hypothesis]. Kuroki T Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Oct; 24(5):257-64. PubMed ID: 15658501 [TBL] [Abstract][Full Text] [Related]
15. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Meltzer HY; Huang M Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033 [TBL] [Abstract][Full Text] [Related]
16. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review]. Khaldi S; Kornreich C; Choubani Z; Gourevitch R Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460 [TBL] [Abstract][Full Text] [Related]
17. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Kuroki T; Nagao N; Nakahara T Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034 [TBL] [Abstract][Full Text] [Related]
18. Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics. Stip E J Psychiatry Neurosci; 2000 Mar; 25(2):137-53. PubMed ID: 10740987 [TBL] [Abstract][Full Text] [Related]
19. [Biochemical mechanism of action of neuroleptics (author's transl)]. Scatton B Encephale; 1981; 7(3):201-14. PubMed ID: 6116590 [TBL] [Abstract][Full Text] [Related]
20. The new antipsychotics. How much better are they? Keks N; Mazumdar P; Steele K Aust Fam Physician; 2000 May; 29(5):445-50. PubMed ID: 10835782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]